(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -51.31%318.03K | -69.88%79.65K | -47.96%92.26K | -33.20%77.42K | -28.24%68.77K | 62.40%653.16K | 139.79%264.46K | 73.28%177.27K | 20.91%115.9K | 2.26%95.83K |
Selling and administrative expenses | -70.30%92.8K | -93.19%15K | 140.04%48.01K | -66.34%18.3K | -35.47%11.5K | 310.19%312.42K | 376.77%220.26K | 147.71%20K | 297.28%54.35K | 7.99%17.82K |
-General and administrative expense | -70.30%92.8K | -93.19%15K | 140.04%48.01K | -66.34%18.3K | -35.47%11.5K | 310.19%312.42K | 376.77%220.26K | 147.71%20K | 297.28%54.35K | 7.99%17.82K |
Other operating expenses | -33.90%225.23K | 46.26%64.65K | -71.86%44.25K | -3.94%59.12K | -26.59%57.27K | 4.51%340.74K | -31.03%44.2K | 66.90%157.27K | -25.10%61.55K | 1.03%78.01K |
Operating profit | 51.31%-318.03K | 69.88%-79.65K | 47.96%-92.26K | 33.20%-77.42K | 28.24%-68.77K | -62.40%-653.16K | -225.00%-264.46K | -58.36%-177.27K | -9.86%-115.9K | 7.28%-95.83K |
Net non-operating interest income (expenses) | 79.76%1.51K | 2 | -15.60%709 | 0 | 799 | 1,135.29%840 | 0 | 840 | 0 | 0 |
Non-operating interest income | 79.76%1.51K | --2 | -15.60%709 | --0 | --799 | 1,135.29%840 | --0 | --840 | --0 | --0 |
Other net income (expenses) | 83.92%-43.25K | -66.67%67 | -19.77%-269.02K | 131.03%201 | 308.70%96 | |||||
Gain on sale of security | ---- | ---- | ---- | -66.67%67 | ---- | 1,385.00%257 | ---- | ---- | 131.03%201 | 308.70%96 |
Special income (charges) | 83.94%-43.25K | ---- | ---- | ---- | ---- | -19.90%-269.27K | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | -83.94%43.25K | ---- | ---- | ---- | ---- | -10.59%269.27K | ---- | ---- | ---- | ---- |
Income before tax | 60.95%-359.77K | 76.96%-122.9K | 48.11%-91.55K | 33.14%-77.35K | 29.00%-67.97K | -47.01%-921.34K | -39.44%-533.47K | -399.05%-176.43K | -9.76%-115.69K | 7.41%-95.74K |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 60.95%-359.77K | 76.96%-122.9K | 48.11%-91.55K | 33.14%-77.35K | 29.00%-67.97K | -47.01%-921.34K | -39.44%-533.47K | -399.05%-176.43K | -9.76%-115.69K | 7.41%-95.74K |
Net income continuous operations | 60.95%-359.77K | 76.96%-122.9K | 48.11%-91.55K | 33.14%-77.35K | 29.00%-67.97K | -47.01%-921.34K | -39.44%-533.47K | -399.05%-176.43K | -9.76%-115.69K | 7.41%-95.74K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 60.95%-359.77K | 76.96%-122.9K | 48.11%-91.55K | 33.14%-77.35K | 29.00%-67.97K | -47.01%-921.34K | -39.44%-533.47K | -399.05%-176.43K | -9.76%-115.69K | 7.41%-95.74K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 60.95%-359.77K | 76.96%-122.9K | 48.11%-91.55K | 33.14%-77.35K | 29.00%-67.97K | -47.01%-921.34K | -39.44%-533.47K | -399.05%-176.43K | -9.76%-115.69K | 7.41%-95.74K |
Diluted earnings per share | 50.00%-0.02 | 50.00%-0.01 | 58.21%-0.0042 | 33.38%-0.0035 | 37.12%-0.0031 | -33.33%-0.04 | -15.77%-0.02 | -442.89%-0.01 | 47.00%-0.0053 | 8.42%-0.0049 |
Basic earnings per share | 50.00%-0.02 | 50.00%-0.01 | 58.21%-0.0042 | 33.38%-0.0035 | 37.12%-0.0031 | -33.33%-0.04 | -15.77%-0.02 | -442.89%-0.01 | 47.00%-0.0053 | 8.42%-0.0049 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.